Single-use Chromatography Systems Market Size, Share, Trend, Forecast Report 2026 to 2035

What is Single-use Chromatography Systems Market Size?

Global Single-use Chromatography Systems Market Size is valued at USD 1.39 Bn in 2025 and is predicted to reach USD 5.14 Bn by the year 2035 at a 14.2% CAGR during the forecast period for 2026 to 2035.

Single-use Chromatography Systems Market Size, Share & Trends Analysis by Scale of Operation (Preclinical and Clinical, and Commercial), End User (Pharma and Biopharmaceutical Companies, CROs and CMOs, and Other End Users)), and Segment Forecasts, 2026 to 2035.

The term single-use chromatography systems defines disposable downstream processing technologies utilized in separation, purification, and concentration of biological products. Examples of the latter include, but are not limited to, monoclonal antibodies, vaccines, recombinant proteins, viral vectors, and various advanced biologicals. As opposed to traditional steel chromatography systems, which contain fixed process paths including tubing, valves, and other hardware, single-use platforms involve use of disposables. This eliminates cleaning, validation, and changeover needs associated with switching between batches. Single-use chromatography platforms are widely implemented today in downstream biopharmaceutical manufacturing owing to increased flexibility of multiproduct plants along with accelerated process development and scale-up. Flexibility of manufacturing, biologics production increase, and adoption of single-use technology are the main drivers for the single-use chromatography systems market growth. As an illustration, the Resolute Flowdrive SU platform offered by Sartorius is designed for clinical as well as commercial-scale manufacturing with a wide range of configurations for diverse flow rates and chromatography modes.

Moreover, the growing need in flexible manufacturing, increase in biologics, biosimilars, vaccines, as well as cell and gene therapy production resulted in the expansion of the single-use chromatography systems market. Today more and more biopharmaceutical manufacturers and contract development and manufacturing organizations are seeking for technologies, which will enable them to switch between different products without any considerable changes in their facilities. Single-use chromatography systems meet this need through decreasing cleaning requirements and accelerating changeover times. Single-use chromatography is suitable for facilities, producing a variety of products in relatively small or medium-sized batches.
At the same time, the transition to process intensification leads to changes in design of downstream purification. Companies are shifting from packed-bed batch mode to such new technologies as membrane chromatography, pre-packed columns, monoliths and multi-columns approach. For instance, the Sartorius BioSMB platform, which is designed for single-use multi-column capture, allows reduction of resin amounts and supports higher capacity. Therefore, the single-use chromatography market gradually moves from disposable components into integrated automation.

Competitive Landscape

Which are the Leading Players in Single-use Chromatography Systems Market?

• Danaher (Cytiva and Pall)
• Sartorius
• Thermo Fisher Scientific
• Merck KGaA
• Repligen
• Bio-Rad Laboratories
• Tosoh Bioscience
• 3M
• Purolite
• Agilent Technologies
• Avantor
• Eppendorf
• KNAUER Wissenschaftliche Geräte
• YMC
• Natrix Separations

Market Dynamics

Driver

Growing Adoption of Flexible and Modular Biopharmaceutical Manufacturing

Market growth of the single-use chromatography systems is expected owing to the ongoing adoption of flexible manufacturing by biopharmaceutical companies. Traditional stainless steel chromatography systems are difficult to clean, clean validate and prepare prior to use in production campaigns. Since single-use technologies make it easier to replace components involved in direct contact with the process fluid, they provide an appealing option for multiproduct sites and CDMOs which have to switch products from time to time.
This trend will be amplified further by the trend towards small-scale, flexible manufacturing facilities, allowing single-use to minimize demands on substantial fixed infrastructure, making it possible for manufacturers to configure their systems in accordance with the specifics of particular processes. Sartorius claims that its Resolute Flowdrive SU system offers flexibility as its modular design allows for clinical and commercial-scale manufacturing using various flow kits, columns, membranes, and monoliths.
Other important factor is the emergence of complex biologic drugs. Monoclonal antibodies have been dominant but such therapeutic classes as viral vectors, vaccines, bispecific antibodies, antibody-drug conjugates and many others have to be purified through a process that can be optimized in relation to product's specificities.

Restrain/Challenge

High Consumable Costs and Waste Management Requirements

Among the major issues surrounding the growth of the single-use chromatography systems market worldwide is the cost involved with disposables. While systems made of stainless steel can be re-used for a series of campaigns, single-use systems demand fresh flow paths and other process contact disposables after use, making this solution expensive and thus impacting operating costs, especially where there is a high volume commercial manufacturing.
Secondly, there is also an issue of waste disposal. The waste of bags, tubing, filters, flow paths and other plastic components will have to be dealt with. In view of the growing need for sustainability among biopharmaceutical companies, suppliers are expected to come up with low material-intensity disposable systems and recycling solutions.
Thus, while it might appear economical to use single-use chromatography systems due to reduction in the cost of cleanups and the lower demands that such systems have in terms of facility needs, the economic value will still depend on the manufacturing paradigm.

Production-scale Segment is Expected to Drive the Single-use Chromatography Systems Market

It is anticipated that production-scale systems will make up a significant percentage of single-use chromatography systems due to increased commercial biologics production. Production-scale systems offer the appropriate flow rate, pressure control, and process capability required for both clinical and commercial purification processes.

The trend towards higher-titer biologicals is also increasing the need for capacity in downstream processing equipment. The companies will need to have chromatography systems capable of handling larger processing volumes in order to prevent purification bottlenecks. The production single-use systems allow the companies to have more flexibility without the infrastructure associated with traditional stainless-steel systems.
Biopharmaceutical Manufacturing Segment is Growing at the Highest Rate in the Single-use Chromatography Systems Market
The biopharmaceutical manufacturing segment will continue to dominate the market due to the importance of chromatography in the downstream process. Biologics like monoclonal antibodies, recombinant proteins, vaccines, viral vectors, etc. need many purification steps in order to ensure the necessary product purity and quality.

The growing number of biologics in clinical development makes it necessary to have scalable systems for purification. In clinical development, single-use chromatography can prove to be very helpful as the production specifications may change during optimization process. A disposable system can make it much easier to transfer technology and prepare equipment for a particular product.

Why Europe Led the Single-use Chromatography Systems Market?

According to the current industry estimates, Europe will hold a key position within the single use batch chromatography systems market due to its strong manufacturing industry, significant presence of the biotech companies, well-established CDMOs, and adoption of the downstream technologies.

The second key geographical market is Asia Pacific because of its well-established infrastructure of the pharmaceuticals manufacturing plants and significant presence of significant players. 

Single-use Chromatography Systems Market Report Scope: